Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arylia vs Prolia in Postmenopausal Osteoporosis
NCT03293108Phase 3Unknown
- Sponsor
- AryoGen Biopharma
- Start
- Apr 2017
- Primary completion
- Sep 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of Arylia in osteoporosis, sponsored by AryoGen Biopharma. Status: unknown.
02
Drugs
Arylia
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03293108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03293108.